Samuel D Rabkin

17PUBLICATIONS
19CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 25, 2026
Triple-Survival Stereotactic Brain Surgeries for the Intracranial Injections of Glioblastoma Stem-like Cells and Oncolytic Herpes Simplex Viruses.

|Sep 16, 2025
Promoting the therapeutic potential of interleukin-7 (IL-7) by expression in viral vectors.

Myla Hudson, Robert H Newman, Checo J Rorie

|Feb 03, 2025
Immunocompetent murine glioblastoma stem-like cell models exhibiting distinct phenotypes.

Kimia Kardani, Shanawaz M Ghouse, Muzammil Arif Din Abdul Jabbar

|May 31, 2024
Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?

Hongbin Wang, Mia Borlongan, Howard L Kaufman

|Apr 10, 2024
Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival.

Praveen K Bommareddy, Hiroaki Wakimoto, Robert L Martuza

|Aug 14, 2023
Viral Vectors Expressing Interleukin 2 for Cancer Immunotherapy.

Hongbin Wang, Mia Borlongan, Akseli Hemminki

Pageof 3

Frequent Collaborators

6 joint publications

Hiroaki Wakimoto

5 joint publications

Howard L Kaufman

5 joint publications

Dipongkor Saha

4 joint publications

Praveen K Bommareddy